GlassScriptPhysician profile
Trini Vega
NPI 1295975407
$4,610.28
in general payments reported to CMS, 2019-2025
8 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $465 · 2021: $497 · 2022: $915 · 2023: $629 · 2024: $879 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,566.15 | 2019-2025 | Dysport |
| Allergan, INC. | $1,327.09 | 2019-2022 | |
| Abbvie INC. | $761.27 | 2023-2025 | Botox |
| Merz North America, INC. | $544.77 | 2019-2024 | |
| Apyx Medical Corporation | $299.15 | 2019-2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $65.54 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $24.33 | 2022 | |
| Medline Industries LP | $21.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trini Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.